- Report
- October 2024
- 194 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- August 2024
- 175 Pages
Global
From €4772EUR$5,000USD£3,998GBP
- Report
- July 2024
- 100 Pages
Global
From €3579EUR$3,750USD£2,999GBP
- Report
- March 2025
- 184 Pages
Global
From €5345EUR$5,600USD£4,478GBP
- Report
- March 2025
- 294 Pages
Global
From €5201EUR$5,450USD£4,358GBP
- Report
- June 2024
- 190 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- September 2024
- 250 Pages
Global
From €4767EUR$4,995USD£3,994GBP
- Clinical Trials
- July 2022
- 60 Pages
Global
From €2147EUR$2,250USD£1,799GBP
- Report
- October 2023
- 145 Pages
Global
From €3006EUR$3,150USD£2,519GBP
- Report
- July 2024
- 280 Pages
Global
From €2534EUR$2,655USD£2,123GBP
The Artificial Lung is a medical device used to provide oxygen to patients with severe respiratory failure. It is a type of extracorporeal membrane oxygenation (ECMO) device, which is a form of life support that oxygenates the blood outside of the body. Artificial Lungs are used to treat a variety of conditions, including acute respiratory distress syndrome, chronic obstructive pulmonary disease, and cardiogenic shock. The device works by removing carbon dioxide from the blood and replacing it with oxygen, allowing the patient to breathe more easily.
The Artificial Lung market is a rapidly growing segment of the medical device industry. It is driven by the increasing prevalence of respiratory diseases, as well as advances in technology that have made the devices more efficient and cost-effective. Artificial Lungs are becoming increasingly popular in hospitals and other healthcare settings, as they provide a safe and effective way to treat patients with severe respiratory failure.
Some of the major companies in the Artificial Lung market include Medtronic, Getinge, Maquet, and Sorin Group. Show Less Read more